LisaBethYanoffMD

Diabetes, Lipid Metabolism

Acting Director, Division of Metabolism and Endocrinology Products US FDA

Dr. Yanoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10903 New Hampshire Avenue
room 3118
Silver Spring, MD 20903
Phone+1 301-796-3834

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2008
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2000 - 2003
University of Maryland School of MedicineClass of 2000

PubMed

108 citations
Obesity-Related Hypoferremia Is Not Explained by Differences in Reported Intake of Heme and Nonheme Iron or Intake of Dietary Factors that Can Affect Iron Absorption
Carolyn M. Menzie, Lisa B. Yanoff, Blakeley I. Denkinger, Teresa McHugh, Nancy G. Sebring
Journal of the American Dietetic Association. 2008-01-01
233 citations
Inflammation and iron deficiency in the hypoferremia of obesity.
Lisa B. Yanoff, Carolyn M. Menzie, Blakeley I. Denkinger, Nancy G. Sebring, Teresa McHugh
International Journal of Obesity. 2007-04-17
33 citations
Oxygen-uptake efficiency slope as a determinant of fitness in overweight adolescents.
Bart Drinkard, Mary D. Roberts, Lisa M. Ranzenhofer, Joan C. Han, Lisa B. Yanoff
Medicine and Science in Sports and Exercise. 2007-10-01

FDA Approves New Treatment for Pediatric Patients with Type 2 DiabetesNovember 4th, 2019
First Oral GLP-1 Receptor Agonist Approved for Type 2 DiabetesSeptember 23rd, 2019
FDA Approves First Oral GLP-1 Treatment for Type 2 DiabetesSeptember 20th, 2019
Join now to see all